Prospera Financial Services Inc Crispr Therapeutics Ag Transaction History

Prospera Financial Services Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$51.17 - $68.18 $194,957 - $259,765	3,810 New	3,810 $205,000
Q1 2024 Aug 13, 2024	BUY	$60.67 - $89.12 $24,753 - $36,360	408 Added 10.71%	4,218 $287,000
Q2 2022 Aug 08, 2022	SELL	$43.23 - $73.83 $10,375 - $17,719	-240 Reduced 15.13%	1,346 $82,000
Q1 2022 May 04, 2022	BUY	$53.19 - $79.24 $84,359 - $125,674	1,586 New	1,586 $100,000
Q4 2020 Feb 12, 2021	SELL	$79.67 - $173.23 $47,483 - $103,245	-596 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$78.5 - $100.64 $46,786 - $59,981	596 New	596 $50,000

503

57M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.03B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.